D A I LY N E W S
ASCRS
F R I DAY, A P R I L 2 2 , 2 0 2 2 | A S C R S A N N UA L M E E T I N G
DAILY NEWS
E
yeWorld
spoke to
ASCRS
President
Richard Hoffman,
MD, about his time
as president, the
challenges faced,
goals, and more.
EyeWorld: This past year has con-
tinued to see challenges from the
pandemic for ophthalmologists both on
the personal and professional levels as
well as for the society and the medical
community as a whole; can you speak
to that? How have physicians and the
society adapted to move forward?
Dr. Hoffman: The initial challenges
from the COVID-19 pandemic have,
for the most part, been alleviated with
masking, social distancing, slit lamp
screens, and temperature and symp-
tom screenings within our practice.
Although we are not back to 100%
patient volume, we are close, and as
the pandemic eases, things should
return to normal in most practices. One
of the things that struck me during the
pandemic was how reliant all medical
societies are on their annual meetings,
and ASCRS is no different. The Annual
Meeting is the life blood of our organi-
zation, and although we were able to
maintain the education and sharing of
resources with a virtual meeting and
other outreach, the virtual education
was no substitute for a live, in-person
gathering.
D
ouglas
Rhee,
MD, will
become
the president of
ASCRS at the
Opening General
Session. He spoke
with EyeWorld
about his thoughts on the current
and future state of the society and his
insights on the field of ophthalmology
as a whole.
EyeWorld: How and when did you first
become involved with ASCRS?
continued on page 4
continued on page 3
EXPERIENCE
DEXTENZA
© 2022 Ocular Therapeutix, Inc. All rights reserved.
DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0411
LEARN MORE AT
DEXTENZA.COM
VISIT BOOTH 1315
Now Oering Our
First FDA Approved Drug
09/2021 US-DEX-2100225
DEXYCU, the DEXYCU logo, and the
EyePoint logo are registered trademarks of
EyePoint Pharmaceuticals, Inc. ©2022
EyePoint Pharmaceuticals, Inc. All rights
reserved. 480 Pleasant Street, Suite B300,
Watertown, MA 02472
ImprimisRx is a registered trademark of
Harrow Health Inc. ©2022 ImprimisRx, Inc.
All Rights Reserved. IMPO0555Rev1 03/22
12264 1000 Aviara Pkwy, Suite 220
Carlsbad, CA 92011
Booth #2001
Visit us at ASCRS
Outgoing ASCRS President Richard Hoffman, MD,
discusses his time as president
Interview with incoming ASCRS President
Douglas Rhee, MD
Dr. Rhee: I first started coming to the
ASCRS Annual Meeting in 1999. I was
a senior resident. It happened to be in
Philadelphia, and that's where I was
doing my residency, so I decided to
check it out. I became involved with
the organization itself when I was invit-
ed by Reay Brown, MD, to serve on the
Glaucoma Clinical Committee in 2006.
EyeWorld: Over this time, what drove
your continued engagement with
ASCRS?
Friday, April 22, 2022
ASCRS Annual Meeting
Find ASCRS and EyeWorld on social media u
